Driscoll Frederick W
- SEC CIK
- 0001129890
No open-market purchases or sales filed in the past year.
Current role at each company
- CLRB Cellectar Biosciences, Inc.Directoras of Jul 8, 2026
- LITS Lite Strategy, Inc.Directoras of Nov 18, 2025
- CUE Cue Biopharma, Inc.Directoras of Jan 3, 2025
- RCOR Renovacor, Inc.Chief Financial Officeras of Mar 28, 2022
- FLXN Flexion Therapeutics IncChief Financial Officeras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Driscoll Frederick W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CLRB Cellectar Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 (view filing) | Sep 3 | 4 days | Driscoll Frederick WDirector | PPurchase | +19.4K | $1.04 | +$20.2K | New position19.4K after |